- Presentations
- 0
- Brands
- 0
- Manufacturers
- 0
- Available from stock
- 0
Imlifidase is a medicine. It is available for export supply from India to licensed hospitals, importers and physicians, with the documents the destination country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Key facts
- ATC classification
- L04AA Immunosuppressive drug, subgroup L04AA · Immunosuppressive drug
- US FDA first approval
- Not recorded
- EU status
- Authorised
- Orphan designation
- Yes
- WHO essential medicine
- Not recorded
- India (CDSCO)
- Not yet confirmed against CDSCO approval lists
- Identifiers
- UNII UVJ7NL8S2PCAS 1947415-68-0DrugBank DB15258Q97353944
All presentations
No presentations of Imlifidase are listed yet. Ask us to source it
Regulatory status
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
Questions and answers
Is Imlifidase available for export from India?
No presentation of Imlifidase is listed yet, but our sourcing team can check licensed channels. Send a request with the strength, quantity and destination country.
Is Imlifidase authorised in the European Union?
Yes. Imlifidase has a central EU marketing authorisation (status: authorised), according to European Medicines Agency data.
Does Imlifidase need cold chain shipping?
No listed presentation of Imlifidase is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Which ATC class is Imlifidase in?
Imlifidase is classified under ATC code L04AA (Immunosuppressive drug, subgroup L04AA).
References
- Idefirix: European public assessment report (EPAR). European Medicines Agency. Retrieved 16 October 2026
Request Imlifidase for export supply
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.